CN103751245B - One treats dermopathic Chinese medicine composition and uses thereof - Google Patents
One treats dermopathic Chinese medicine composition and uses thereof Download PDFInfo
- Publication number
- CN103751245B CN103751245B CN201310699544.7A CN201310699544A CN103751245B CN 103751245 B CN103751245 B CN 103751245B CN 201310699544 A CN201310699544 A CN 201310699544A CN 103751245 B CN103751245 B CN 103751245B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- medicine composition
- treatment
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 114
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 239000003921 oil Substances 0.000 claims abstract description 44
- 201000004624 Dermatitis Diseases 0.000 claims abstract description 12
- 206010040943 Skin Ulcer Diseases 0.000 claims abstract description 12
- 208000010668 atopic eczema Diseases 0.000 claims abstract description 12
- 208000017520 skin disease Diseases 0.000 claims abstract description 12
- 231100000019 skin ulcer Toxicity 0.000 claims abstract description 12
- 201000009053 Neurodermatitis Diseases 0.000 claims abstract description 8
- 239000011505 plaster Substances 0.000 claims abstract description 6
- 239000000839 emulsion Substances 0.000 claims abstract description 5
- 239000000499 gel Substances 0.000 claims abstract description 5
- 239000006210 lotion Substances 0.000 claims abstract description 4
- 239000002674 ointment Substances 0.000 claims abstract description 4
- 229940098465 tincture Drugs 0.000 claims abstract description 4
- -1 tincture Substances 0.000 claims abstract description 3
- 235000019198 oils Nutrition 0.000 claims description 43
- 229940079593 drug Drugs 0.000 claims description 38
- 238000002360 preparation method Methods 0.000 claims description 29
- 239000004006 olive oil Substances 0.000 claims description 24
- 235000008390 olive oil Nutrition 0.000 claims description 24
- 238000001816 cooling Methods 0.000 claims description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- 206010048768 Dermatosis Diseases 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000002386 leaching Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract description 26
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract description 26
- 240000001851 Artemisia dracunculus Species 0.000 abstract description 26
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract description 26
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract description 26
- 241000208152 Geranium Species 0.000 abstract description 26
- 241001647091 Saxifraga granulata Species 0.000 abstract description 26
- 239000001138 artemisia absinthium Substances 0.000 abstract description 26
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 26
- 239000002994 raw material Substances 0.000 abstract description 22
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 206010040882 skin lesion Diseases 0.000 description 23
- 231100000444 skin lesion Toxicity 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 208000003251 Pruritus Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 230000006872 improvement Effects 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 230000007803 itching Effects 0.000 description 12
- 208000011580 syndromic disease Diseases 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 229920000742 Cotton Polymers 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 206010024438 Lichenification Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010012435 Dermatitis and eczema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 201000007902 Primary cutaneous amyloidosis Diseases 0.000 description 1
- 241000206469 Pulsatilla Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗皮肤病的中药组合物及其用途,它由以下重量份的原料药制成:艾草20-40份、老鹳草40-60份、虎耳草40-60份,所述的中药组合物的药剂可以是洗剂、酊剂、油剂、乳剂、软膏剂、硬膏剂或凝胶剂。该中药组合物治疗皮肤病尤其是湿疹、神经性皮炎和皮肤溃疡疗效显著,治愈率高,同时该中药组合物药味数少,制备简便,成本低,且是通过皮肤给药,毒副作用小,安全性高,易于被患者接受。The invention relates to a traditional Chinese medicine composition for treating skin diseases and its application. It is made of the following raw materials in parts by weight: 20-40 parts of wormwood, 40-60 parts of geranium, 40-60 parts of saxifrage, The medicament of the traditional Chinese medicine composition can be lotion, tincture, oil, emulsion, ointment, plaster or gel. The traditional Chinese medicine composition has remarkable curative effect in treating skin diseases, especially eczema, neurodermatitis and skin ulcer, and has a high cure rate. At the same time, the traditional Chinese medicine composition has few medicinal flavors, is easy to prepare, low in cost, and is administered through the skin with little toxic and side effects. High safety, easy to be accepted by patients.
Description
【技术领域】【Technical field】
本发明涉及一种治疗皮肤病的中药组合物及其用途,具体地说,是一种以中草药为原料制备的中成药。The invention relates to a traditional Chinese medicine composition for treating skin diseases and its application, in particular, it is a Chinese patent medicine prepared from Chinese herbal medicines.
【背景技术】【Background technique】
湿疹是由多种内外因素引起的瘙痒剧烈的一种皮肤炎症反应。分急性、亚急性、慢性三期。急性期具渗出倾向,慢性期则浸润、肥厚。一般湿疹的皮损为多形性,以红斑、丘疹、丘疱疹为主,皮疹中央明显,逐渐向周围散开,境界不清,弥漫性,有渗出倾向,慢性者则有浸润肥厚。Eczema is a skin inflammatory reaction with severe itching caused by various internal and external factors. Divided into acute, subacute and chronic stages. In the acute phase, it tends to exudate, while in the chronic phase, it is infiltrating and hypertrophic. Generally, the skin lesions of eczema are pleomorphic, mainly erythema, papule, and papuular herpes. The rash is obvious in the center and gradually spreads to the surroundings. The boundary is unclear, diffuse, and has a tendency to exudate.
神经性皮炎又称慢性单纯性苔藓,是一种以皮肤苔藓样变及剧烈瘙痒为特征的慢性炎症性疾病,一般认为本病的发生可能系大脑皮质抑制和兴奋功能紊乱所致,精神紧张、焦虑、抑郁,局部刺激(如摩擦、日盼、多汗)以及消化不良、饮酒、进食辛辣等均可诱发或加重本病。Neurodermatitis, also known as lichen simplex chronicus, is a chronic inflammatory disease characterized by skin lichenification and severe itching. It is generally believed that the occurrence of this disease may be caused by cerebral cortex inhibition and excitatory dysfunction. Anxiety, depression, local stimuli (such as friction, sunburn, sweating) and indigestion, drinking, eating spicy food, etc. can induce or aggravate the disease.
皮肤溃疡是中医外科常见病、多发病,是以皮肤溃疡为主要临床表现长期不能愈合为临床特征,皮肤组织缺损液化感染坏死的一种体表疾病,此处泛指中医外科疮疡类溃后长期未愈者。由于疮面难以愈合且消耗甚大,给患者造成了很大的心理压力和经济损失,严重影响患者的身体健康及生活质量。Skin ulcer is a common and frequently-occurring disease in traditional Chinese medicine surgery, with skin ulcer as the main clinical manifestation and long-term non-healing as the clinical feature. Those who have not recovered for a long time. Because the sore surface is difficult to heal and consumes a lot, it causes great psychological pressure and economic loss to the patient, and seriously affects the patient's health and quality of life.
目前用于治疗以上皮肤病的中药种类较多,如中国专利文献CN201310358800.6,公开日2013.11.13,公开了一种治疗皮炎湿疹类疾病的复合中药外用制剂,其特征是由下列重量百分比的原料和药学上可接受的载体制备而成:蛇油3-15份、紫草3-12份、四季青10-45份。其剂型为乳膏剂、乳剂、搽剂、脂质体或喷雾剂。该发明应用于皮炎湿疹类疾病的临床治疗,具有抗炎、抗过敏、抗菌、保湿等作用,且效果显著。中国专利文献CN201110338788.3,公开日2013.05.08,公开了一种治疗皮肤溃疡的中药制剂,该中药制剂由下列重量份的原料药制备而成:黄连0.5-2份、黄柏0.5-2份、白头翁1-3份、马齿苋1-3份、玄明粉2-4份、土槿皮1-3份、红花0.5-2份。该中药制剂可制成片剂、合剂、颗粒剂和胶囊剂,外用具有清热利湿、凉血解毒、消肿止痛之功效,主治各种皮肤溃疡,尤其适用于治疗下肢静脉曲张性溃疡、外伤性溃疡、感染性溃疡等皮肤创面以局部红肿渗出为主要症状的病症。而研究开发更多的可广泛治疗各类皮肤病、组分少、成本低的中药组合物仍然是十分必要的。At present, there are many types of traditional Chinese medicines used to treat the above skin diseases. For example, Chinese patent document CN201310358800.6, published on November 13, 2013, discloses a compound traditional Chinese medicine external preparation for treating dermatitis and eczema, which is characterized by the following weight percentage It is prepared from raw materials and a pharmaceutically acceptable carrier: 3-15 parts of snake oil, 3-12 parts of comfrey and 10-45 parts of Sijiqing. Its dosage form is cream, emulsion, liniment, liposome or spray. The invention is applied to the clinical treatment of dermatitis and eczema diseases, and has the functions of anti-inflammation, anti-allergy, antibacterial, moisturizing, etc., and the effect is remarkable. Chinese patent document CN201110338788.3, published on 2013.05.08, discloses a traditional Chinese medicine preparation for treating skin ulcers. 1-3 parts of pulsatilla, 1-3 parts of purslane, 2-4 parts of Xuanming powder, 1-3 parts of hibiscus bark, and 0.5-2 parts of safflower. The traditional Chinese medicine preparation can be made into tablets, mixtures, granules and capsules. External use has the effects of clearing away heat and dampness, cooling blood and detoxification, reducing swelling and relieving pain. Skin wounds such as sexual ulcers and infectious ulcers are characterized by local redness, swelling and exudation as the main symptom. It is still very necessary to research and develop more traditional Chinese medicine compositions that can widely treat various skin diseases, have few components, and have low cost.
【发明内容】【Content of invention】
本发明的目的是针对现有技术中的不足,提供一种治疗皮肤病的中药组合物。The object of the present invention is to provide a traditional Chinese medicine composition for treating skin diseases in view of the deficiencies in the prior art.
本发明的再一的目的是,提供上述中药组合物的制备方法。Another object of the present invention is to provide a preparation method of the above-mentioned traditional Chinese medicine composition.
本发明的另一的目的是,提供上述中药组合物的用途。Another object of the present invention is to provide the application of the above-mentioned traditional Chinese medicine composition.
为实现上述目的,本发明采取的技术方案是:For realizing above-mentioned object, the technical scheme that the present invention takes is:
一种治疗皮肤病的中药组合物,它由以下重量份的原料药制成:艾草20-40份、老鹳草40-60份、虎耳草40-60份。A traditional Chinese medicine composition for treating skin diseases is prepared from the following raw materials in parts by weight: 20-40 parts of wormwood, 40-60 parts of geranium, and 40-60 parts of saxifrage.
优选地,所述的中药组合物由以下重量份的原料药制成:艾草25-35份、老鹳草45-55份、虎耳草45-55份。Preferably, the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 25-35 parts of wormwood, 45-55 parts of geranium, and 45-55 parts of saxifrage.
更优选地,所述的中药组合物由以下重量份的原料药制成:艾草30份、老鹳草50份、虎耳草50份。More preferably, the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 30 parts of wormwood, 50 parts of geranium, and 50 parts of saxifrage.
所述的中药组合物的药剂是洗剂、酊剂、油剂、乳剂、软膏剂、硬膏剂或凝胶剂。The medicament of the traditional Chinese medicine composition is lotion, tincture, oil, emulsion, ointment, plaster or gel.
优选地,所述的中药组合物的药剂是油剂。Preferably, the agent of the traditional Chinese medicine composition is an oil agent.
优选地,所述的油剂中作为辅料的植物油是橄榄油。Preferably, the vegetable oil used as an auxiliary material in the oil agent is olive oil.
为实现上述第二个目的,本发明采取的技术方案是:For realizing above-mentioned second purpose, the technical scheme that the present invention takes is:
一种如上所述的中药组合物的制备方法,包括以下步骤:按重量份称取艾草20-40份、老鹳草40-60份、虎耳草40-60份,加入600-1200份橄榄油,浸泡24-72小时,然后微火煎熬至原料药焦黑,自然冷却后过滤取油。A preparation method of the above-mentioned traditional Chinese medicine composition, comprising the following steps: weighing 20-40 parts of wormwood, 40-60 parts of geranium, and 40-60 parts of saxifrage by weight, and adding 600-1200 parts Olive oil, soak for 24-72 hours, then decoct on low heat until the raw material is burnt black, cool naturally and filter to get the oil.
为实现上述第三个目的,本发明采取的技术方案是:For realizing above-mentioned 3rd purpose, the technical scheme that the present invention takes is:
如上任一所述的中药组合物在制备治疗皮肤病药物中的用途。Use of the traditional Chinese medicine composition as described above in the preparation of medicines for treating skin diseases.
所述的皮肤病是湿疹、神经性皮炎或皮肤溃疡。The skin disease is eczema, neurodermatitis or skin ulcer.
本发明优点在于:The present invention has the advantage that:
1、治疗皮肤病尤其是湿疹、神经性皮炎和皮肤溃疡疗效显著,治愈率高;1. It is effective in treating skin diseases, especially eczema, neurodermatitis and skin ulcers, with a high cure rate;
2、药味数少,仅三味药,制备简单,成本低;2. Fewer medicinal flavors, only three flavors, simple preparation and low cost;
3、通过皮肤给药,毒副作用小,安全性高,易于被患者接受。3. Drug administration through the skin has less toxic and side effects, high safety, and is easy to be accepted by patients.
【具体实施方式】【detailed description】
下面对本发明提供的具体实施方式作详细说明。The specific implementation manners provided by the present invention will be described in detail below.
实施例1本发明中药组合物制备(一)Embodiment 1 Preparation of Chinese medicine composition of the present invention (1)
按重量份称取艾草30份、老鹳草50份、虎耳草50份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油。Weigh 30 parts of wormwood, 50 parts of geranium, and 50 parts of saxifrage by weight, add 900 parts of olive oil, soak for 48 hours, then simmer on low heat for about 7 hours until the raw material is charred, cool naturally, filter and take the oil .
实施例2本发明中药组合物制备(二)Embodiment 2 Preparation of Chinese medicine composition of the present invention (two)
按重量份称取艾草20份、老鹳草60份、虎耳草40份,加入1200份橄榄油,浸泡24小时,然后微火煎熬约8小时至原料药焦黑,自然冷却后过滤取油。Weigh 20 parts of wormwood, 60 parts of geranium, and 40 parts of saxifrage by weight, add 1200 parts of olive oil, soak for 24 hours, then simmer on low heat for about 8 hours until the raw material is charred, cool naturally, filter and take the oil .
实施例3本发明中药组合物制备(三)Embodiment 3 Preparation of Chinese medicine composition of the present invention (three)
按重量份称取艾草40份、老鹳草40份、虎耳草60份,加入600份橄榄油,浸泡72小时,然后微火煎熬约6小时至原料药焦黑,自然冷却后过滤取油。Weigh 40 parts of wormwood, 40 parts of geranium, and 60 parts of saxifrage by weight, add 600 parts of olive oil, soak for 72 hours, then simmer on low heat for about 6 hours until the raw material is charred, cool naturally, filter and take the oil .
实施例4本发明中药组合物制备(四)Embodiment 4 Preparation of Chinese medicine composition of the present invention (four)
按重量份称取艾草20份、老鹳草40份、虎耳草60份,加入1200份橄榄油,浸泡72小时,然后微火煎熬约6小时至原料药焦黑,自然冷却后过滤取油。Weigh 20 parts of wormwood, 40 parts of geranium, and 60 parts of saxifrage by weight, add 1200 parts of olive oil, soak for 72 hours, then simmer on low heat for about 6 hours until the raw material is charred, cool naturally, filter and take the oil .
实施例5本发明中药组合物制备(五)Embodiment 5 Preparation of Chinese medicine composition of the present invention (five)
按重量份称取艾草25份、老鹳草55份、虎耳草45份,加入600份橄榄油,浸泡72小时,然后微火煎熬约8小时至原料药焦黑,自然冷却后过滤取油。Weigh 25 parts of wormwood, 55 parts of geranium, and 45 parts of saxifrage by weight, add 600 parts of olive oil, soak for 72 hours, then decoct on low heat for about 8 hours until the raw material is charred, cool naturally, filter and take the oil .
实施例6本发明中药组合物制备(六)Embodiment 6 Preparation of Chinese medicine composition of the present invention (6)
按重量份称取艾草35份、老鹳草45份、虎耳草55份,加入800份橄榄油,浸泡60小时,然后微火煎熬约6小时至原料药焦黑,自然冷却后过滤取油。Weigh 35 parts of wormwood, 45 parts of geranium, and 55 parts of saxifrage by weight, add 800 parts of olive oil, soak for 60 hours, then simmer for about 6 hours until the raw material is charred, cool naturally, filter and take the oil .
实施例7本发明中药组合物制备(七)Embodiment 7 Preparation of Chinese medicine composition of the present invention (7)
按重量份称取艾草40份、老鹳草60份、虎耳草60份,加入1000份橄榄油,浸泡36小时,然后微火煎熬约8小时至原料药焦黑,自然冷却后过滤取油。Weigh 40 parts of wormwood, 60 parts of geranium, and 60 parts of saxifrage by weight, add 1000 parts of olive oil, soak for 36 hours, then decoct on low heat for about 8 hours until the raw material is charred, cool naturally, filter and take the oil .
实施例8本发明中药组合物制备(八)Embodiment 8 Preparation of Chinese medicine composition of the present invention (eight)
按重量份称取艾草40份、老鹳草40份、虎耳草60份,加入1000份橄榄油,浸泡36小时,然后微火煎熬约6小时至原料药焦黑,自然冷却后过滤取油。Weigh 40 parts of wormwood, 40 parts of geranium, and 60 parts of saxifrage by weight, add 1000 parts of olive oil, soak for 36 hours, then simmer on low heat for about 6 hours until the raw material is charred, cool naturally, filter and take the oil .
实施例9本发明中药组合物洗剂的制备The preparation of embodiment 9 Chinese medicine composition lotion of the present invention
按权利要求1-8任一所述的重量份称取艾草、老鹳草、虎耳草,加8-12倍量水,煎煮3-4小时,滤出药汁,再加5-6倍量水,煎煮2-3小时,滤出药汁,合并二次煎液。Take wormwood, geranium, and saxifrage according to any one of claims 1-8 by weight, add 8-12 times the amount of water, decoct for 3-4 hours, filter out the concoction, and add 5- 6 times the amount of water, decoct for 2-3 hours, filter out the medicinal juice, and combine the second decoction.
实施例10本发明中药组合物酊剂的制备The preparation of embodiment 10 Chinese medicine composition tincture of the present invention
按权利要求1-8任一所述的重量份称取艾草、老鹳草、虎耳草,加8-12倍量水,煎煮3-4小时,滤出药汁,再加5-6倍量水,煎煮2-3小时,滤出药汁,合并二次煎液,静置,滤取上清液,浓缩,放冷,加浓缩液2.5倍量酒精,搅拌沉淀过夜。取上清液,浓缩至稠浸膏,加规定浓度为60%乙醇适量,溶解或稀释,静置,即得。Take wormwood, geranium, and saxifrage according to any one of claims 1-8 by weight, add 8-12 times the amount of water, decoct for 3-4 hours, filter out the concoction, and add 5- 6 times the amount of water, decoct for 2-3 hours, filter out the medicinal juice, combine the second decoction, let it stand, filter the supernatant, concentrate, let it cool, add 2.5 times the amount of alcohol to the concentrated solution, stir and precipitate overnight. Take the supernatant, concentrate to a thick extract, add an appropriate amount of ethanol with a specified concentration of 60%, dissolve or dilute, and let stand to obtain.
实施例11本发明中药组合物乳剂的制备The preparation of embodiment 11 Chinese medicine composition emulsion of the present invention
按权利要求1-8任一所述的重量份称取艾草、老鹳草、虎耳草,加8-12倍量水,煎煮3-4小时,滤出药汁,再加5-6倍量水,煎煮2-3小时,滤出药汁,合并二次煎液,静置,滤取上清液,浓缩,放冷,加浓缩液2.5倍量酒精,搅拌沉淀过夜。取上清液,浓缩至稠浸膏。取大豆油,加入阿拉伯胶粉研磨均匀,按油:水:胶为4:2:1的比例加入蒸馏水,研磨至初乳。将稠浸膏与初乳混合,充分搅拌均匀即可。Take wormwood, geranium, and saxifrage according to any one of claims 1-8 by weight, add 8-12 times the amount of water, decoct for 3-4 hours, filter out the concoction, and add 5- 6 times the amount of water, decoct for 2-3 hours, filter out the medicinal juice, combine the second decoction, let it stand, filter the supernatant, concentrate, let it cool, add 2.5 times the amount of alcohol to the concentrated solution, stir and precipitate overnight. Take the supernatant and concentrate to a thick extract. Take soybean oil, add gum arabic powder and grind evenly, add distilled water according to the ratio of oil: water: gum 4:2:1, grind until colostrum. Mix the thick extract with colostrum and stir well.
实施例12本发明中药组合物软膏剂的制备The preparation of embodiment 12 Chinese medicine composition ointment of the present invention
按权利要求1-8任一所述的重量份称取艾草、老鹳草、虎耳草,加8-12倍量水,煎煮3-4小时,滤出药汁,再加5-6倍量水,煎煮2-3小时,滤出药汁,合并二次煎液,静置,滤取上清液,加蜂蜡和黄凡士林适量,再文火(约100℃)煎熬15-30min,冷却成膏状物即得。Take wormwood, geranium, and saxifrage according to any one of claims 1-8 by weight, add 8-12 times the amount of water, decoct for 3-4 hours, filter out the concoction, and add 5- 6 times the amount of water, decoct for 2-3 hours, filter out the medicinal juice, combine the second decoction, let it stand, filter the supernatant, add appropriate amount of beeswax and yellow vaseline, and decoct at a slow fire (about 100°C) for 15-30min , cooled to a paste that is.
实施例13本发明中药组合物硬膏剂的制备The preparation of embodiment 13 Chinese medicine composition plaster of the present invention
按权利要求1-8任一所述的重量份称取艾草、老鹳草、虎耳草,打碎。将植物油(如菜籽油、花生油等)置锅中,微热后将上述药料投入,加热并不断搅拌,直至药料炸至表面深褐色内部焦黄为度。炸好后用铁丝捞去药渣,去渣后的油为药油。取药油继续熬炼至滴水成珠。炼成后,离火下丹,一般500g油加250g丹,黄丹在下前先干燥并过100目筛,少量加丹,边加边搅动直至搅成粘稠的膏体。喷水法去“火毒”后,用竹签取一定量的膏药在牛皮纸或膏药布上即可,麝香以及易挥发的冰片、樟脑、薄荷等可最后撒上。Take by weighing wormwood, geranium, saxifrage according to the arbitrary described weight portion of claim 1-8, break into pieces. Put vegetable oil (such as rapeseed oil, peanut oil, etc.) in a pot, put the above-mentioned ingredients into the pot after slightly heating, heat and stir constantly, until the ingredients are fried until the surface is dark brown and the inside is brown. After frying, remove the dregs with iron wire, and the oil after removing the dregs is medicinal oil. Take the medicated oil and continue refining until dripping into beads. After refining, remove the dan from the fire, generally add 250g dan to 500g oil, dry the yellow dan first and pass through a 100-mesh sieve, add a small amount of dan, and stir until it becomes a viscous paste. After the "fire poison" is removed by spraying water, take a certain amount of plaster with a bamboo stick and put it on kraft paper or plaster cloth. Musk and volatile borneol, camphor, mint, etc. can be sprinkled on at last.
实施例14本发明中药组合物凝胶剂的制备Embodiment 14 Preparation of Chinese medicine composition gel of the present invention
按权利要求1-8任一所述的重量份称取艾草、老鹳草、虎耳草,打碎。将少量植物油(如菜籽油、花生油等)置锅中,微热后将上述药料投入,加热煎熬并不断搅拌,取滤液。将卡波姆加入甘油中研磨使湿润,再加入少量蒸馏水研磨后,移到量杯中,另取三乙醇胺、羟苯乙脂、蒸馏水适量使溶解,搅拌成凝胶状,再加适量蒸馏水搅匀,加入上述药材滤液,研匀即得。Take by weighing wormwood, geranium, saxifrage according to the arbitrary described weight portion of claim 1-8, break into pieces. Put a small amount of vegetable oil (such as rapeseed oil, peanut oil, etc.) in a pot, put the above medicinal materials into the pot after slightly heating, heat and decoct with constant stirring, and take the filtrate. Add carbomer to glycerin and grind it to make it moist, then add a small amount of distilled water to grind it, then move it to a measuring cup, take another appropriate amount of triethanolamine, ethylparaben, and distilled water to dissolve, stir it into a gel, add an appropriate amount of distilled water and mix well , add the above-mentioned medicinal material filtrate, and grind until uniform.
实施例15本发明中药组合物治疗湿疹的临床试验Embodiment 15 Clinical trials of Chinese medicine composition of the present invention treating eczema
1、选择病例1. Select a case
从皮肤科门诊选择患者120例,所有患者均符合湿疹的诊断标准并符合主要皮损对称性的特点。其中男性为52例,女性为68例,年龄最小者18岁,最大者60岁,平均年龄为(38.02±16.37)岁。病程最短者为1周,病程最长者为3年,平均病程为(9.25±13.08)个月。研究对象的皮损分布情况:头面部、上肢、躯干、下肢所占比例分别为23.58%、50.39%、45.61%、41.71%。A total of 120 patients were selected from the dermatology clinic. All patients met the diagnostic criteria of eczema and met the characteristics of the symmetry of the main skin lesions. Among them, there were 52 males and 68 females. The youngest was 18 years old, the oldest was 60 years old, and the average age was (38.02±16.37) years old. The shortest course was 1 week, the longest course was 3 years, and the average course was (9.25±13.08) months. The distribution of skin lesions of the research objects: the proportions of the head and face, upper limbs, trunk and lower limbs were 23.58%, 50.39%, 45.61%, and 41.71%, respectively.
2、治疗方法2. Treatment method
(1)治疗组:用温水洗净患处,揩干后取采用实施例1制备的中药组合物油剂,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,疗程14天,患者于治疗后第14天复诊,治疗期间不用内服药物。(1) Treatment group: wash the affected part with warm water, wipe it dry, take the Chinese medicine composition oil preparation prepared in Example 1, evenly smear the affected part of the skin with a cotton swab, and give it according to the dosage of about 2g crude drug crude drug/ cm2 of the skin lesion. Medicine, once in the morning and once in the evening, and the course of treatment is 14 days. The patient will return to the clinic on the 14th day after treatment, and no internal medicine is needed during the treatment.
(2)对照组一:按重量份称取艾草55份、老鹳草75份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,得该组治疗用中药油剂。给药方法及疗程同治疗组。(2) Control group 1: Weigh 55 parts of wormwood and 75 parts of geranium by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the crude drug is burnt black, filter and take after natural cooling oil, get this group of Chinese medicine oil for treatment. The administration method and course of treatment were the same as those of the treatment group.
(3)对照组二:按重量份称取艾草55份、虎耳草75份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,得该组治疗用中药油剂。给药方法及疗程同治疗组。(3) Control group 2: Take 55 parts of wormwood and 75 parts of saxifrage by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the raw material medicine is scorched black, filter and take after natural cooling oil, get this group of Chinese medicine oil for treatment. The administration method and course of treatment were the same as those of the treatment group.
(4)对照组三:按重量份称取老鹳草65份、虎耳草65份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,得该组治疗用中药油剂。给药方法及疗程同治疗组。(4) Control group 3: Weigh 65 parts of geranium and 65 parts of saxifrage by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the raw material is burnt black, and filter after natural cooling Get the oil to get this group of Chinese medicinal oils for treatment. The administration method and course of treatment were the same as those of the treatment group.
3、疗效观察和评定指标3. Curative effect observation and evaluation indicators
分别于治疗前及治疗后复诊时对患者进行湿疹面积和严重指数(EASI)评分。The eczema area and severity index (EASI) was scored before and after treatment.
3.1湿疹面积和严重度指数(EASI)3.1 Eczema Area and Severity Index (EASI)
根据表1和表2所示,分别对患者头颈部、躯干、上肢、下肢的皮损面积及皮损严重程度进行评分,计算各部分的EASI值,最后根据总EASI分值=A+B+C+D求出治疗组、对照组一-对照组三的总EASI值。According to Table 1 and Table 2, the skin lesion area and severity of the patient's head and neck, trunk, upper limbs, and lower limbs were scored respectively, and the EASI value of each part was calculated. Finally, the total EASI score = A+B +C+D Calculate the total EASI value of the treatment group, control group 1-control group 3.
表1EASI评分表(8岁以上)Table 1 EASI scoring table (over 8 years old)
注:E为红斑,I为水肿或丘疹,Ex为表皮剥脱,L为苔藓样变。Note: E is erythema, I is edema or papule, Ex is exfoliation, L is lichenification.
表2EASI评分细则Table 2 EASI Scoring Rules
3.2总体疗效评价3.2 Overall curative effect evaluation
疗效指标为治疗前后EASI评分的变化值及治疗前后EASI评分改善率。各组治疗前后EASI评分的变化值和改善率定义为:EASI评分变化值=疗前EASI评分-疗后EASI评分;EASI评分改善率=(疗前EASI评分-疗后EASI评分)/疗前EASI评分×100%。The curative effect indicators were the change value of EASI score before and after treatment and the improvement rate of EASI score before and after treatment. The change value and improvement rate of EASI score before and after treatment in each group were defined as: EASI score change value = EASI score before treatment - EASI score after treatment; EASI score improvement rate = (EASI score before treatment - EASI score after treatment) / EASI score before treatment Score × 100%.
根据治疗前后的临床改善程度,计算主要疗效指标,按痊愈、显效、进步、无效4级标准进行治疗结束时疗效总评估。痊愈EASI评分改善率>90%,瘙痒消失。显效EASI评分改善率60%-89%,瘙痒明显减轻。进步EASI评分改善率20%-59%,瘙痒瘙痒减轻。无效EASI评分改善率<20%,瘙痒同治疗前或加剧。将痊愈病例和显效病例合计为有效病例,计算有效率。According to the degree of clinical improvement before and after treatment, the main curative effect index is calculated, and the total curative effect evaluation at the end of the treatment is carried out according to the 4 grades of recovery, marked effect, progress, and ineffectiveness. The recovery rate of EASI score was >90%, and the itching disappeared. Significantly, the improvement rate of EASI score is 60%-89%, and the itching is obviously relieved. The improvement rate of progressive EASI score is 20%-59%, and itching is relieved. Ineffective EASI score improvement rate < 20%, pruritus same as before treatment or aggravated. The cured cases and markedly effective cases were combined as effective cases to calculate the effective rate.
4、统计学方法4. Statistical methods
采用SPSS18.0统计学软件进行统计学处理,计量资料以均数±标准差(mean±sd)表示,采用t检验,计数资料采用χ2检验。SPSS 18.0 statistical software was used for statistical processing, measurement data were expressed as mean ± standard deviation (mean ± sd), t test was used, and χ2 test was used for count data.
5、治疗结果5. Treatment results
4.1各组治疗前后EASI值变化4.1 Changes of EASI value in each group before and after treatment
各组治疗前后EASI值变化情况见表3。治疗前治疗组和对照组的平均EASI值无统计学差异(P>0.05),具有可比性。治疗14天后,各组的平均EASI值较治疗前均有下降,治疗组的治疗后评分与对照组一-对照组三任一组治疗后评分相比,差异有统计学意义(P<0.05)。The changes of EASI values before and after treatment in each group are shown in Table 3. There was no significant difference in the average EASI value between the treatment group and the control group before treatment (P>0.05), and they were comparable. After 14 days of treatment, the average EASI value of each group decreased compared with that before treatment, and the post-treatment scores of the treatment group were significantly different from those of the control group 1-control group 3 after treatment (P<0.05) .
表3各组EASI评分比较Table 3 Comparison of EASI scores in each group
4.2各组治疗后疗效及有效率比较4.2 Comparison of curative effect and effective rate after treatment in each group
各组治疗后疗效及有效率结果见表4。治疗14天后,治疗组有效率与对照组一-对照组三任一组相比,差异有统计学意义(P<0.05),对照组一-对照组三之间有效率无统计学差异(P>0.05)。The curative effect and effective rate results of each group after treatment are shown in Table 4. After 14 days of treatment, the effective rate of the treatment group was significantly different from that of the control group 1-control group 3 (P<0.05), and there was no significant difference in the effective rate between the control group 1-control group 3 (P >0.05).
表4各组治疗后疗效及有效率比较Table 4 Comparison of curative effect and effective rate after treatment in each group
实施例16本发明中药组合物治疗神经性皮炎的临床试验Clinical trial of embodiment 16 Chinese medicine composition of the present invention treating neurodermatitis
1、一般资料1. General Information
临床收集120例患者中,年龄18-70岁,平均年龄36岁,病程在3个月到8年,平均4.3年。Clinically collected 120 patients, aged 18-70 years, with an average age of 36 years, and the course of disease ranged from 3 months to 8 years, with an average of 4.3 years.
2、诊断标准2. Diagnostic criteria
诊断依据国家中医药管理局颁发的《中医病证诊断疗效标准》:The diagnosis is based on the "Standards for the Diagnosis and Curative Effect of Diseases and Syndromes of Traditional Chinese Medicine" issued by the State Administration of Traditional Chinese Medicine:
(1)发生在颈侧、腰骶、肘部等部位,有显著瘙痒;(1) Occur in the neck, lumbosacral, elbow and other parts, with significant itching;
(2)皮疹融合成片,皮肤增厚粗糙,皮沟加深,皮嵴隆起,有苔藓样化及色素沉着;(2) The rash merges into sheets, the skin is thickened and rough, the skin grooves are deepened, the skin ridges are raised, and there are lichenification and pigmentation;
(3)病程慢性经过,渗出倾向。(3) Chronic course of disease, exudation tendency.
3、排除标准3. Exclusion criteria
慢性湿疹、原发性皮肤淀粉样变、特应性皮炎、扁平苔癣、癌痒症,治疗前1周停用过抗组胺药及糖及质激素,其他脏器疾病、孕妇和哺乳期患者除外。Chronic eczema, primary cutaneous amyloidosis, atopic dermatitis, lichen planus, cancer itch, antihistamines and sugar and hormone hormones stopped 1 week before treatment, other organ diseases, pregnant women and lactating period Patients are excluded.
4、治疗方法4. Treatment method
(1)治疗组:用温水洗净患处,轻揩干后取实施例1制备的中药组合物油剂,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,10天为一疗程,治疗6个疗程后复诊,治疗期间不用内服药物。(1) Treatment group: wash the affected part with warm water, dry it lightly, take the Chinese medicine composition oil preparation prepared in Example 1, evenly smear the affected part of the skin with a cotton swab, and give it according to the dosage of about 2g crude drug crude drug/ cm2 of the skin lesion. Medicine, once in the morning and evening, 10 days as a course of treatment, follow-up consultation after 6 courses of treatment, no internal medicine is needed during the treatment.
(2)对照组一:按重量份称取艾草55份、老鹳草75份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,得治疗用中药油剂。给药方法及疗程同治疗组。(2) Control group 1: Weigh 55 parts of wormwood and 75 parts of geranium by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the crude drug is burnt black, filter and take after natural cooling Oil, Chinese medicine oil for treatment. The administration method and course of treatment were the same as those of the treatment group.
(3)对照组二:按重量份称取艾草55份、虎耳草75份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,得治疗用中药油剂。给药方法及疗程同治疗组。(3) Control group 2: Take 55 parts of wormwood and 75 parts of saxifrage by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the raw material medicine is scorched black, filter and take after natural cooling Oil, Chinese medicine oil for treatment. The administration method and course of treatment were the same as those of the treatment group.
(4)对照组三:按重量份称取老鹳草65份、虎耳草65份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,得治疗用中药油剂。给药方法及疗程同治疗组。(4) Control group 3: Weigh 65 parts of geranium and 65 parts of saxifrage by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the raw material is burnt black, and filter after natural cooling Get the oil to get the Chinese medicine oil for treatment. The administration method and course of treatment were the same as those of the treatment group.
5、评分标准5. Scoring criteria
采用0-3级标准评分对治疗前及治疗后患者疼痒程度、苔鲜样变数目及大小(最小直径)、肥厚程度、色素沉着进行评分。0分为无痒感,皮肤光滑,色素肤色;1分为偶有瘙痒,不烦躁,皮损直径<0.5cm,皮损1-6个,轻度苔鲜样变,色素淡红;2分为中度瘙痒,但能耐受,皮损直径1.5-2.5cm,皮损7-12个,中度苔鲜样变,色素呈褐色;3分为严重瘙痒,不能忍受,皮损直径>2.5cm,皮损>12个,皮肤肥厚粗糙,呈苔醉样变及深褐色。上述5项分数相加为总积分。积分下降指数=[(治疗前总积分-治疗后总积分)/治疗前总积分]×100%。The degree of pain and itching, the number and size (minimum diameter) of moss-like changes, the degree of hypertrophy, and pigmentation of patients before and after treatment were scored using a 0-3 scale standard score. 0: No itching, smooth skin, pigmented skin; 1: Occasional itching, no irritability, skin lesion diameter <0.5cm, 1-6 skin lesions, mild mossy change, light red pigment; 2 points Moderate itching, but tolerable, lesions 1.5-2.5 cm in diameter, 7-12 lesions, moderate mossy change, brown pigment; 3 points, severe itching, intolerable, lesions > 2.5 cm in diameter cm, with more than 12 skin lesions, the skin is thick and rough, mossy and dark brown. The above 5 scores are added together for the total score. Integral decrease index=[(total integral before treatment-total integral after treatment)/total integral before treatment]×100%.
参照《中医病证诊断疗效标准》制定:治愈,积分下降指数≥90%;显效,积分下降指数为60%-89%;有效,积分下降指数为20%-59%;无效,积分下降指数≤90%。将治愈病例、显效病例和有效病例合计,计算有效率。According to the "Diagnosis and Curative Effect Standards of Traditional Chinese Medicine Diseases and Syndromes": cured, the integral decline index is ≥90%; markedly effective, the integral decline index is 60%-89%; effective, the integral decline index is 20%-59%; invalid, the integral decline index is ≤ 90%. The cured cases, markedly effective cases and effective cases were summed up to calculate the effective rate.
6、治疗结果6. Treatment results
各组治疗后疗效及有效率结果见表5。治疗6个疗程后,治疗组有效率与对照组一-对照组三任一组有效率相比,差异有统计学意义(P<0.05)。The curative effect and effective rate results of each group after treatment are shown in Table 5. After 6 courses of treatment, the effective rate of the treatment group was significantly different from that of the control group 1-control group 3 (P<0.05).
表5各组治疗后疗效及有效率比较Table 5 Comparison of curative effect and effective rate after treatment in each group
实施例17本发明中药组合物治疗皮肤溃疡的临床试验Embodiment 17 The clinical trial of Chinese medicine composition of the present invention treating skin ulcer
1、一般资料1. General Information
入选标准:凡符合皮肤溃疡1个月以上未愈合者及中医证候诊断标准中属于湿热证者。年龄在18-75岁的患者,性别不限。Inclusion criteria: Those with skin ulcers that have not healed for more than 1 month and those with Damp-Heat Syndrome in the TCM Syndrome Diagnostic Criteria. Patients aged 18-75, regardless of gender.
2、诊断标准2. Diagnostic criteria
(1)西医诊断标准:皮肤溃疡1个月以上未愈合者。(1) Diagnostic criteria of Western medicine: skin ulcers that have not healed for more than 1 month.
(2)中医证候诊断标准:属湿热证者,参照《中华人民共和国国家标准·中医临床诊疗术语·证候》、《中华人民共和国中医药行业标准·中医病证诊断疗效标准》及国家统编教材《中医外科学》(新世纪全国高等中医药院校教材)。(2) Diagnostic criteria of TCM syndromes: For those with damp-heat syndrome, refer to "National Standards of the People's Republic of China·Terms of Clinical Diagnosis and Treatment of Traditional Chinese Medicine·Syndrome", "Standards of the People's Republic of China Traditional Chinese Medicine Industry Standards for the Diagnosis and Efficacy of TCM Disease Syndromes" and the National Standards Compiled the textbook "Surgical Medicine of Traditional Chinese Medicine" (a new century national textbook for higher Chinese medicine colleges).
主症:创面腐暗,脓水浸淫,秽臭难闻,四周红肿灼热,痒痛时作。Main symptoms: The wound surface is rotten and dark, soaked in pus, foul smell, redness, swelling and burning around, and sometimes itching.
次症:恶寒发热、口渴、便秘、溲赤;舌红或苔腻,脉滑数。Secondary symptoms: aversion to cold and fever, thirst, constipation, red urination; red tongue or greasy coating, slippery and rapid pulse.
具备湿热证上述主症两项及次症两项即可作出诊断。The diagnosis can be made if there are two main symptoms and two secondary symptoms of the above-mentioned damp-heat syndrome.
3、纳入标准3. Inclusion criteria
符合本病西医诊断标准和中医证候诊断标准;皮肤溃疡创面面积≥2cm2;年龄≥18周岁且≤75周岁,男女不限,知情同意,签署知情同意书,并自愿受试。Meet the diagnostic criteria of Western medicine and TCM syndromes of this disease; skin ulcer wound area ≥ 2cm 2 ; age ≥ 18 years old and ≤ 75 years old, male or female, informed consent, sign the informed consent form, and voluntarily undergo the test.
4、排出标准4. Discharge standard
不符合诊断标准和纳入标准者;或虽符合诊断标准和纳入标准,但有下列情况之一者:合并有心血管、脑血管、肝、肾和造血系统等严重原发性疾病,精神病患者,肿瘤或艾滋病患者;妊娠或哺乳期妇女,过敏体质者;合并严重感染,病情危重者;合并糖尿病,血糖控制不稳定者;合并神经营养障碍者;动脉疾病性溃疡、癌性溃疡或结核性溃疡、放射性溃疡、褥疮、麻风性溃疡、梅毒性溃疡;溃疡并见肌腱、骨骼暴露者;符合纳入标准,但未按规定用药,无法判断疗效,或资料不全者。Those who do not meet the diagnostic criteria and inclusion criteria; or those who meet the diagnostic criteria and inclusion criteria, but have one of the following conditions: combined with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, mental illness, tumors or AIDS patients; pregnant or breastfeeding women, those with allergic constitution; those with severe infection and critical condition; those with diabetes and unstable blood sugar control; those with neurotrophic disorders; Radiation ulcers, decubitus ulcers, leprosy ulcers, syphilitic ulcers; ulcers with exposed tendons and bones; those who meet the inclusion criteria, but do not use the prescribed medication, cannot judge the curative effect, or have incomplete data.
5、治疗方法5. Treatment
(1)治疗组:采用实施例1制备的中药组合物油剂,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,治疗4周为1疗程,3疗程后判效,治疗期间不用内服药物。(1) treatment group: adopt the Chinese medicine composition oil preparation prepared by embodiment 1, evenly smear the affected part of the skin lesion with a cotton swab, according to about 2g crude drug crude drug/cm 2 dosage administration of the skin lesion, sooner or later each once, treat for 4 weeks 1 course of treatment, after 3 courses of treatment, the effect will be judged, and no internal medicine is needed during the treatment.
(2)对照组一:按重量份称取艾草130份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,治疗4周为1疗程,3疗程后判效,治疗期间不用内服药物。(2) Control group 1: Weigh 130 parts of wormwood by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the raw material is burnt black, filter and take the oil after natural cooling, and evenly smear it with a cotton swab For the affected part of the skin lesion, the dosage of about 2g raw drug crude drug/cm 2 skin lesion is administered, once in the morning and once in the evening, 4 weeks of treatment is a course of treatment, and the effect will be judged after 3 courses of treatment. During the treatment period, no internal medicine is needed.
(2)对照组二:按重量份称取老鹳草130份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,治疗4周为1疗程,3疗程后判效,治疗期间不用内服药物。(2) Control group 2: Weigh 130 parts of geranium by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the raw material is burnt black, filter the oil after natural cooling, and use a cotton swab to evenly Apply to the affected area of skin lesions, and administer according to the dose of about 2g crude drug crude drug/cm 2 skin lesions, once in the morning and once in the evening, 4 weeks of treatment is a course of treatment, and the effect will be judged after 3 courses of treatment. No internal medicine is needed during the treatment.
(4)对照组三:按重量份称取虎耳草130份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,治疗4周为1疗程,3疗程后判效,治疗期间不用内服药物。(4) Control group 3: Weigh 130 parts of saxifrage by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the raw material is burnt black, filter the oil after natural cooling, and use a cotton swab to evenly Apply to the affected area of skin lesions, and administer according to the dose of about 2g crude drug crude drug/cm 2 skin lesions, once in the morning and once in the evening, 4 weeks of treatment is a course of treatment, and the effect will be judged after 3 courses of treatment. No internal medicine is needed during the treatment.
(5)对照组四:按重量份称取艾草55份、老鹳草75份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,治疗4周为1疗程,3疗程后判效,治疗期间不用内服药物。(5) Control group 4: Weigh 55 parts of wormwood and 75 parts of geranium by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the raw material is burnt black, filter and take after natural cooling Oil, evenly smear the skin lesion with a cotton swab, and administer according to the dose of about 2g crude drug crude drug/cm 2 skin lesion, once in the morning and once in the evening, 4 weeks of treatment is a course of treatment, and the effect will be judged after 3 courses of treatment. No internal medicine is needed during the treatment.
(6)对照组五:按重量份称取艾草55份、虎耳草75份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,治疗4周为1疗程,3疗程后判效,治疗期间不用内服药物。(6) Control group five: take by weight 55 parts of wormwood and 75 parts of saxifrage, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the crude drug is scorched black, filter and take after natural cooling Oil, evenly smear the skin lesion with a cotton swab, and administer according to the dose of about 2g crude drug crude drug/cm 2 skin lesion, once in the morning and once in the evening, 4 weeks of treatment is a course of treatment, and the effect will be judged after 3 courses of treatment. No internal medicine is needed during the treatment.
(7)对照组六:按重量份称取老鹳草65份、虎耳草65份,加入900份橄榄油,浸泡48小时,然后微火煎熬约7小时至原料药焦黑,自然冷却后过滤取油,用棉签均匀涂抹皮损患处,按照约2g原料药生药/cm2皮损的剂量给药,早晚各一次,治疗4周为1疗程,3疗程后判效,治疗期间不用内服药物。(7) Control group 6: Weigh 65 parts of geranium and 65 parts of saxifrage by weight, add 900 parts of olive oil, soak for 48 hours, then decoct on low heat for about 7 hours until the crude drug is burnt black, filter after natural cooling Take the oil, apply it evenly on the skin lesion with a cotton swab, and administer the drug according to the dose of about 2g crude drug/cm 2 skin lesion, once in the morning and once in the evening, 4 weeks of treatment is a course of treatment, and the effect will be judged after 3 courses of treatment. During the treatment period, no internal medicine is needed.
6、疗效评价指标6. Curative effect evaluation index
参照《中医病证诊断疗效标准》、《上海市中医病证诊疗常规》(第2版)判定:临床痊愈:改善率≥95%以上;显效:70%≤改善率<95%;有效:30%≤改善率<70%;无效:改善率<30%。总有效率=痊愈率+显效率+有效率。Refer to "Diagnosis and Curative Effect Criteria of TCM Diseases and Syndromes" and "Shanghai Traditional Chinese Medicine Diseases and Syndrome Diagnosis and Treatment Routine" (2nd Edition) to determine: clinical recovery: improvement rate ≥ 95%; marked effect: 70% ≤ improvement rate < 95%; effective: 30% %≤improvement rate<70%; invalid: improvement rate<30%. Total effective rate = recovery rate + marked rate + effective rate.
7、治疗结果7. Treatment results
各组的总有效率统计结果见表6,结果表明治疗组总有效率显著高于对照组一-对照组六任一组(P<0.05),其中与对照组一-对照组三的差异达到极显著水平(P<0.01),对照组四-对照组五之间比较差异不显著(P>0.05),还可看出,治疗组的治愈速度快,治疗3个疗程后痊愈和显效人数多。The statistical results of the total effective rate of each group are shown in Table 6. The results show that the total effective rate of the treatment group is significantly higher than that of the control group 1-control group 6 (P<0.05), and the difference from the control group 1-control group 3 reaches Extremely significant level (P<0.01), there was no significant difference between control group 4 and control group 5 (P>0.05). It can also be seen that the cure rate in the treatment group is fast, and the number of people who are cured and markedly effective after 3 courses of treatment is large .
表6各组总有效率统计结果Table 6 The statistical results of the total effective rate of each group
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员,在不脱离本发明方法的前提下,还可以做出若干改进和补充,这些改进和补充也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that for those of ordinary skill in the art, without departing from the method of the present invention, some improvements and supplements can also be made, and these improvements and supplements should also be considered Be the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310699544.7A CN103751245B (en) | 2013-12-19 | 2013-12-19 | One treats dermopathic Chinese medicine composition and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310699544.7A CN103751245B (en) | 2013-12-19 | 2013-12-19 | One treats dermopathic Chinese medicine composition and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103751245A CN103751245A (en) | 2014-04-30 |
CN103751245B true CN103751245B (en) | 2016-04-06 |
Family
ID=50518672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310699544.7A Active CN103751245B (en) | 2013-12-19 | 2013-12-19 | One treats dermopathic Chinese medicine composition and uses thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103751245B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106511410A (en) * | 2017-01-03 | 2017-03-22 | 遵义医学院 | Herba Saxifragae ointment for treating skin diseases and preparation method of Herba Saxifragae ointment for treating skin diseases |
CN107995867A (en) * | 2017-10-27 | 2018-05-04 | 江苏奇力康皮肤药业有限公司 | A kind of long-acting slow-release Chinese medicine cold compress patch for being used to treat skin ulcer |
CN117530996B (en) * | 2023-12-11 | 2024-08-09 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medicine composition for treating atopic dermatitis and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1876046A (en) * | 2006-04-14 | 2006-12-13 | 盛芳 | Traditional Chinese medicine for treating bedsore |
CN101053602A (en) * | 2007-04-25 | 2007-10-17 | 昆明涞章医药科技有限公司 | Medicine for treating oral ulcer and its preparing method |
CN102008593A (en) * | 2010-12-10 | 2011-04-13 | 西安医学院 | Animal antibacterial and anti-virus Chinese medicinal composition and preparation method thereof |
-
2013
- 2013-12-19 CN CN201310699544.7A patent/CN103751245B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1876046A (en) * | 2006-04-14 | 2006-12-13 | 盛芳 | Traditional Chinese medicine for treating bedsore |
CN101053602A (en) * | 2007-04-25 | 2007-10-17 | 昆明涞章医药科技有限公司 | Medicine for treating oral ulcer and its preparing method |
CN102008593A (en) * | 2010-12-10 | 2011-04-13 | 西安医学院 | Animal antibacterial and anti-virus Chinese medicinal composition and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103751245A (en) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6027728A (en) | Herbal skin regeneration composition and method | |
CN108653479A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating refractory skin | |
KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution | |
CN103751245B (en) | One treats dermopathic Chinese medicine composition and uses thereof | |
CN113797250B (en) | External traditional Chinese medicine composition and preparation method and application thereof | |
CN109223860A (en) | A kind of compound five-element grass spray | |
CN106822321B (en) | Application of Curcuma water of traumatology in preparing medicine for treating keratosis pilaris | |
CN115120690B (en) | Traditional Chinese medicine composition for treating precocious puberty and application thereof | |
CN103655814B (en) | One treats psoriatic Chinese medicine composition and application thereof | |
CN103920124B (en) | A kind of bactericidal skin care ointment for frostbite | |
CN102552760A (en) | Nursing liquid for eczema | |
CN108853276B (en) | Compound cream for moistening dryness and relieving itching and preparation method thereof | |
CN111821346A (en) | Topical anti-inflammatory composition | |
CN105327244A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and used for treating bedsores and preparing method thereof | |
CN115429859B (en) | Traditional Chinese medicine composition for treating skin itch diseases and preparation method and application thereof | |
CN103655698B (en) | One treats psoriatic medicine and application thereof | |
CN114028487B (en) | Pharmaceutical composition and preparation for treating acute soft tissue injury | |
CN103933426B (en) | A kind of external preparation for skin disease treatment, preparation and application | |
CN111494571B (en) | Traditional Chinese medicine composition for treating damp-heat blockage type gout and preparation method thereof | |
CN118319989A (en) | External traditional Chinese medicine composition for clearing heat, drying dampness, dispelling wind and relieving itching | |
CN118526546A (en) | Traditional Chinese medicine composition for diminishing inflammation and relieving itching as well as preparation method and application thereof | |
CN106038913B (en) | A kind of traditional Chinese medicine composition for treating gynecological cervicitis and its application | |
CN115590812A (en) | Traditional Chinese medicine ointment for treating hand-foot syndrome and preparation method thereof | |
CN114425061A (en) | A kind of medicinal composition for treating damp-heat accumulation type skin pruritus | |
CN117100790A (en) | Application of Corydalis Corydalis-Angelica Angelica Extract in Preparing Anti-Atopic Dermatitis Drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |